Cell Therapies Competitors and Similar CompaniesClear all

Cell Therapies's competitors and similar companies include Cimeio, Precigen and Mediphage Bioceuticals.
Cell Therapies
Cell Therapies
Cell Therapies is a manufacturer of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products.
Cimeio
Cimeio
Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases.
Precigen
Precigen
Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases.
Mediphage Bioceuticals
Mediphage Bioceuticals
Mediphage Bioceuticals is a genetic medicine company developing a non-viral gene delivery vector platform.
Founding Date
Founding Date
2003
Founding Date
2020
Founding Date
1998
Founding Date
2016
Type
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Melbourne, AU HQ
Locations
Basel, CH HQ
Locations
Germantown, US HQ
Gent, BE
Sioux Center, US
Locations
Toronto, CA HQ
Employees
Employees
733% decrease
Employees
21
Employees
601
Employees
1023% decrease

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 50m (about 4 years ago)
Latest funding round
N/A
Latest funding round
$ 3.5m (over 7 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 50m
Total funding raised
$ 379m
Total funding raised
$ 4.1m
For sources of this data, please see the company profile

View Company Profiles

Cimeio
HQ
Basel, CH
Employees
21

Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases.

View company
Precigen
HQ
Germantown, US
Employees
601

Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases.

View company
Mediphage Bioceuticals
HQ
Toronto, CA
Employees
10↓ 23% decrease

Mediphage Bioceuticals is a genetic medicine company developing a non-viral gene delivery vector platform.

View company